Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.7 |
mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.8 |
mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.024 | 0.8 |
mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.8 |
mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.009 | 0.8 |
mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.8 |
mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |